The most important financial indicators for the company Safa Med Srl - Unique Identification Number 5659399:
sales in 2023 was
71.919
euro, registering a net profit of
18.400
euro and having an average number of
3
employees.
Firma isi desfasoara activitatea in domeniul Inchirierea si subinchirierea bunurilor imobiliare proprii having the NACE code 6820.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -63.7%, from 198.490 euro in the year 2022, to 71.919 euro in 2023.
The Net Profit decreased by -85.560 euro, from 104.276 euro in 2022, to 18.400 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Safa Med Srl - CUI 5659399
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
73.941
70.573
65.908
72.092
66.803
61.620
56.637
51.650
48.068
44.191
Current Assets
24.497
30.103
65.544
55.251
68.806
99.594
82.743
113.492
141.915
53.875
Inventories
0
0
0
74
0
0
42
0
0
0
Receivables
11.491
14.581
13.387
22.524
54.552
18.701
25.037
26.154
34.259
33.076
Cash
13.007
15.522
52.156
32.654
14.254
80.893
57.665
87.338
107.656
20.800
Shareholders Funds
92.224
92.622
103.001
120.204
129.424
142.433
131.896
153.663
175.709
89.616
Social Capital
24.542
24.747
24.495
24.080
23.638
23.180
22.741
22.237
22.306
22.238
Debts
6.215
8.076
28.451
8.135
7.163
19.740
8.729
11.479
14.274
8.450
Income in Advance
0
0
11.137
0
0
0
-305
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"6820 - 6820"
CAEN Financial Year
6820
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
53.875 euro in 2023 which includes Inventories of
0 euro, Receivables of
33.076 euro and cash availability of
20.800 euro.
The company's Equity was valued at
89.616 euro, while total Liabilities amounted to
8.450 euro.
Equity decreased by -85.560 euro, from 175.709 euro in 2022, to 89.616 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Safa Med Srl